Tilia platyphyllos
Tilia platyphyllos, also known as European linden, contains bioactive flavonoids and phenolic acids. It may modulate immune function through peripheral benzodiazepine receptor agonism and shows preliminary anti-cancer potential against pancreatic cells.

Origin & History
Tilia platyphyllos (large-leaved lime or broad-leaved linden) is a deciduous tree native to Central and Southern Europe, with medicinal use primarily from its dried flowers and bracts harvested during flowering. The herbal substance is typically prepared via infusion, decoction, or hydroethanolic extraction methods for traditional teas or research applications.
Historical & Cultural Context
In European traditional medicine, Tilia platyphyllos flowers have been used for over 30 years as tea for colds, cold-related coughs, and associated symptoms, qualifying under EU Directive 2004/24/EC. Commission E has approved it for these traditional indications, typically consumed as an infusion.
Health Benefits
• May support immune function through lymphocyte proliferation via peripheral benzodiazepine receptor agonism (in vitro evidence only) • Shows potential anti-cancer activity against pancreatic cancer cells and tumor progression in animal models (preliminary cell culture and mouse studies) • Exhibits hepatoprotective effects against ethanol-induced liver damage (rat model evidence) • Provides antioxidant support through phenolic compounds including protocatechuic acid and epicatechin (in vitro studies) • Traditional use for cold symptoms and coughs (over 30 years documented use in EU, Commission E approved)
How It Works
Tilia platyphyllos's potential immune support involves lymphocyte proliferation via peripheral benzodiazepine receptor agonism, as observed in in vitro studies. Its anti-cancer activity against pancreatic cancer cells and tumor progression has been noted in preliminary cell culture and mouse studies. The herb also contains flavonoids like quercetin and kaempferol, along with phenolic acids, which contribute to its traditional use as an anxiolytic and anti-inflammatory agent, potentially via GABAergic system modulation.
Scientific Research
No controlled human clinical trials, RCTs, or meta-analyses exist for Tilia platyphyllos according to the European Medicines Agency. Evidence is limited to in vitro studies on MIA PaCa-2 pancreatic cancer cells, HPV16-transgenic mouse models (4.5 mg/10 mL daily for 33 days), and rat hepatoprotection models, with no PubMed PMIDs available for human trials.
Clinical Summary
Current evidence for Tilia platyphyllos primarily stems from in vitro studies and animal models. In vitro research indicates potential immune support via lymphocyte proliferation through peripheral benzodiazepine receptor agonism. Preliminary cell culture and mouse studies demonstrate anti-cancer activity against pancreatic cancer cells and tumor progression. Human clinical trials are very limited, and specific quantified outcomes or optimal dosages are not yet established.
Nutritional Profile
Tilia platyphyllos (large-leaved linden/lime tree) flowers and bracts are the primary used parts. Macronutrient content is minimal in typical herbal preparations (infusions/teas). Key bioactive compounds include: Flavonoids (0.5–1.5% dry weight) dominated by kaempferol and quercetin glycosides, particularly tiliroside (kaempferol-3-O-glucoside-p-coumarate) at approximately 0.3–0.8% dry weight, and hyperoside (quercetin-3-O-galactoside) at 0.1–0.4% dry weight. Phenolic acids include chlorogenic acid and caffeic acid derivatives (0.1–0.3% dry weight). Volatile essential oil fraction (0.02–0.1% fresh weight) contains linalool, geraniol, eugenol, and farnesol as primary components — notably linalool exhibits partial agonist activity at peripheral benzodiazepine receptors relevant to the immune modulation noted. Mucilaginous polysaccharides (3–10% dry weight in flowers) composed of arabinogalactans and glucomannans, contributing to soothing and potentially prebiotic effects; bioavailability of these polysaccharides is low systemically but locally active in GI tract. Proanthocyanidins (condensed tannins) present at approximately 1–2% dry weight. Trace minerals detected in dried flowers include potassium (~400–600 mg/100g dry), calcium (~200–400 mg/100g dry), magnesium (~50–100 mg/100g dry), and manganese (~2–5 mg/100g dry). Vitamin C present in fresh flowers at low concentrations (~10–20 mg/100g fresh weight), largely degraded upon drying or infusion preparation. p-Coumaric acid esters contribute to the hepatoprotective phenolic profile. Flavonoid bioavailability from infusions is estimated at 20–40% relative absorption, enhanced by the presence of quercetin aglycone forms. Standard herbal tea infusion (2g dried flowers/200ml water) yields approximately 5–15 mg total flavonoids per cup.
Preparation & Dosage
No clinically studied human dosages exist. Traditional use involves 1-2 g of dried flowers/bracts per cup (150 mL water), up to 3-4 times daily. Animal studies used hydroethanolic extract at 4.5 mg/10 mL daily orally. Consult a healthcare provider before starting any new supplement.
Synergy & Pairings
Echinacea purpurea, Sambucus nigra, Zingiber officinale, Thymus vulgaris, Glycyrrhiza glabra
Safety & Interactions
Tilia platyphyllos is generally considered safe for short-term consumption. Mild side effects such as gastrointestinal upset or allergic reactions are rare. Due to its potential sedative effects, caution is advised when combined with other central nervous system depressants. Pregnant or breastfeeding individuals should avoid Tilia platyphyllos due to insufficient safety data. Individuals with known allergies to the Tiliaceae family should also exercise caution.